Russian Federation
Russian Federation
Russian Federation
Russian Federation
Russian Federation
myocardial infarction clinical pattern in patients entering hospital and selected for percutaneous coronary interventions, as well as to the study of possible clinical manifestations in the nearest period of the disease and development of measures for secondary prevention of complications
myocardial infarction, possible complications, prevention and preventive therapy of adverse outcomes
1. Polyakov E.L. Voprosy serdechno-sosudistoy patologii na I s'ezde rossiyskih terapevtov (k 100-letiyu s'ezda) // AG. – 2009. – № 5.
2. Zaporozhan N.M., Sapegina F.Z., Karasov I.A. Istoricheskiy obzor razvitiya nepryamyh metodov revaskulyarizacii miokarda // Permskiy medicinskiy zhurnal. – 2023. – № 2.
3. Peel A.A., Semple T., Wang I., Lancaster W.M., Dall J.L. A Coronary prognostic index for grading the severity of infarction. Br Heart J. 1962 Nov; 24(6):745–60. doi:https://doi.org/10.1136/hrt.24.6.745
4. Norris R.M., Brandt P.W., Caughey D.E., Lee A.J., Scott P.J. A new coronary prognostic index // Lancet. – 1969 Feb 8; 1(7589):274–8. doi:https://doi.org/10.1016/s0140-6736(69)91035-6
5. Morrow D.A. et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy // Circulation. – 2000. – T. 102. – № 17. – S. 2031–2037. https://www.ahajournals.org/doi/full/10.1161/01.CIR.102.17.2031
6. Global'nyy reestr ostryh koronarnyh sobytiy (GRACE) (1999–2009). https://www. outcomes-umassmed.org/grace
7. Halkin A., Singh M., Nikolsky E., Grines C.L., Tcheng J.E., Garcia E., Cox D.A., Turco M., Stuckey T.D., Na Y., Lansky A.J., Gersh B.J., O’Neill W.W., Mehran R., Stone G.W. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am CollCardiol. 2005 May 3; 45(9):1397–405. doi:https://doi.org/10.1016/j.jacc.2005.01.041
8. Wilson R.S., Malamas P., Dembo B., Lall S.K., Zaman N., Peterson B.R. The CADILLAC risk score accurately identifies patients at low risk for in-hospital mortality and adverse cardiovascular events following ST elevation myocardial infarction. BMC CardiovascDisord. 2021 Nov 12; 21(1):533. doi:https://doi.org/10.1186/s12872-021-02348-0
9. Schapova N.N., Arsenicheva O.V., Plehanov V.G. Ctratifikaciya riska s ispol'zovaniem shkal GRACE i CADILLAC u pacientov s infarktom miokarda posle intrakoronarnogo vmeshatel'stva. https://vrach-aspirant.ru/articles/cardiovascular_surgery/18022
10. Ardashev V.N., Kalenova I.E., Lyapkova N.B., Potehin N.P., Fursov A.N. Pod redakciey professora Boyarinceva V.V. // Dokazatel'naya medicina: obzor sovremennyh matematicheskih metodov analiza. – Monografiya. – M.: AVN, UNMC UD Prezidenta Rossii, 2013. – S. 224.
